---
title: "667, L.P. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/4be7d3a1-b5ee-571b-b209-42f0058c22ae
json: https://whiteintel.dev/api/public/dossier/4be7d3a1-b5ee-571b-b209-42f0058c22ae
identifier: sec:0001551139
jurisdiction: US
risk: Medium
source: WhiteIntel corporate-ownership graph
---

# 667, L.P.

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001551139`  
**Risk level:** Medium  
**Canonical dossier:** https://whiteintel.dev/entity/4be7d3a1-b5ee-571b-b209-42f0058c22ae  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/4be7d3a1-b5ee-571b-b209-42f0058c22ae  

## Cross-source identity

The same real-world entity, resolved across sources:

- **667, L.P.** — GLEIF · `lei:549300HX7UPMS6S15O35` — https://whiteintel.dev/entity/22684e08-f012-520e-8110-6f4d03c31a58

## Ownership & control

### Holdings / subsidiaries

- **DBV Technologies S.A.** (10% owner) — https://whiteintel.dev/entity/e833c502-aac4-5f5d-bc9c-03df374f0427
- **Immunocore Holdings plc** (director) — https://whiteintel.dev/entity/5a0803a2-bf07-554e-8b32-43d9a7f4d76c
- **Replimune Group, Inc.** (10% owner) — https://whiteintel.dev/entity/2a9e232f-1c55-5a2d-a5ad-a8f772329c57
- **Replimune Group, Inc.** (10% owner) — https://whiteintel.dev/entity/2a9e232f-1c55-5a2d-a5ad-a8f772329c57
- **BeiGene, Ltd.** (director) — https://whiteintel.dev/entity/f5578d61-5548-5f21-9025-ed125e4ab7ca
- **BICYCLE THERAPEUTICS PLC** (10% owner) — https://whiteintel.dev/entity/0acb5729-b5ad-50bb-a9be-f3ce653d4a67
- **IGM Biosciences, Inc.** (10% owner) — https://whiteintel.dev/entity/3608c469-3b96-5030-8ce2-c1e229f9225f
- **INCYTE CORP** (10% owner) — https://whiteintel.dev/entity/1226ba5b-bd76-5385-89a8-2c29a8a06fcf
- **Denali Therapeutics Inc.** (director) — https://whiteintel.dev/entity/73626793-468a-5743-a8c0-5b9d1bed32f4
- **ACADIA PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/e0daead6-1fdc-534a-ae81-4152b4e37d9f
- **INCYTE CORP** (director) — https://whiteintel.dev/entity/1226ba5b-bd76-5385-89a8-2c29a8a06fcf
- **MADRIGAL PHARMACEUTICALS, INC.** (director) — https://whiteintel.dev/entity/beb6f806-b887-5a50-887a-7da069e8acf2

…and **48** more subsidiaries/holdings. Resolve the full list with `get_dossier` on the WhiteIntel MCP (`npx -y @whiteintel/mcp-server`) or a one-off dossier — https://whiteintel.dev/pricing.

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **667, L.P.** — https://whiteintel.dev/entity/4be7d3a1-b5ee-571b-b209-42f0058c22ae · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **667, L.P.**. Human view: https://whiteintel.dev/entity/4be7d3a1-b5ee-571b-b209-42f0058c22ae · Structured JSON: https://whiteintel.dev/api/public/dossier/4be7d3a1-b5ee-571b-b209-42f0058c22ae._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._